LIMN · Liminatus Pharma, Inc. · Earnings Call Transcripts & Audio
$3.47
-0.16 (-4.41%)
At close · Sep 11
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with the Company's assessment of going concern considerations in accordance with Financial Accounting Standards Board ("FASB") ASC 205-40, Presentation of Financial Statements—Going Concern, management has concluded that there is substantial doubt about its ability to continue as a going concern for one year after the date that the accompanying unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$4.66M
Shares
1.34M
Liminatus Pharma, Inc. Earnings Call Transcripts
Quarterly earnings calls for Liminatus Pharma, Inc. (LIMN), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
No Earnings Calls Available
No earnings call events are available for this stock yet.